Part 1

This tender concerns the supply of diagnostic reagents and the lease of specialized equipment for laboratory analysis. Specifically, the procurement includes two types of reagent kits: Collagen/ADP, with 30 packs each containing 20 tests, and Collagen/Epinephrine, also with 30 packs of 20 tests each. These reagents are likely used for platelet aggregation studies, a crucial diagnostic tool in hematology and cardiology to assess platelet function and identify potential bleeding disorders or thrombotic risks. The second component of the tender is the lease of an analyzer, with one unit required for a duration of 36 months. This analyzer is expected to be compatible with the supplied reagents and perform the necessary diagnostic tests. The overall objective is to equip a laboratory facility with the necessary consumables and instrumentation to conduct specific hematological analyses. Further details regarding the technical specifications of the analyzer, delivery timelines, and evaluation criteria are expected to be provided in the full tender documentation. This procurement is essential for ensuring the continuity of diagnostic services and maintaining the operational capacity of the laboratory in its designated healthcare sector.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Medical Equipment and Laboratory. Located in Poland, Europe, this opportunity is open to firms and consortiums, with an estimated budget of PLN 132,786.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.